<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131241">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01393457</url>
  </required_header>
  <id_info>
    <org_study_id>DA030787</org_study_id>
    <nct_id>NCT01393457</nct_id>
  </id_info>
  <brief_title>Cognitive Remediation for Cocaine Dependence</brief_title>
  <official_title>Cognitive-enhancing DA Medications for Cocaine Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate treatments designed to improve cocaine treatment
      success by combining medications that target cocaine-related cognitive impairments.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cocaine use</measure>
    <time_frame>9 weeks</time_frame>
    <description>Use of cocaine based on self-report and urine drug screen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>9 weeks</time_frame>
    <description>Performance on behavioral laboratory tasks measuring cognitive function (e.g., impulsvity, decision-making, motivation, attentional bias).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cocaine Dependence</condition>
  <arm_group>
    <arm_group_label>ldopa + ropinirole low dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>levodopa/carbidopa 800/200 mg/d plus ropinirole 2 mg/d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ldopa + ropinirole high dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>levodopa/carbidopa 800/200 mg/d plus ropinirole 4 mg/d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ldopa</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>levodopa/carbidopa 800/200 mg/d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levodopa/carbidopa</intervention_name>
    <description>800/200 mg/d</description>
    <arm_group_label>ldopa + ropinirole low dose</arm_group_label>
    <arm_group_label>ldopa + ropinirole high dose</arm_group_label>
    <arm_group_label>ldopa</arm_group_label>
    <other_name>ldopa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropinirole</intervention_name>
    <description>2 or 4 mg/d</description>
    <arm_group_label>ldopa + ropinirole low dose</arm_group_label>
    <arm_group_label>ldopa + ropinirole high dose</arm_group_label>
    <other_name>Requip</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>sugar pill</description>
    <arm_group_label>ldopa</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  meet criteria for cocaine dependence

          -  seeking treatment for cocaine dependence

          -  be in acceptable health based on medical history and physical exam

        Exclusion Criteria:

          -  dependent on drugs other than cocaine, nicotine, marijuana

          -  have a medical condition contraindicating treatment with study medications

          -  having conditions of probation or parole requiring reports of drug use to officers of
             the court
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jessica Vincent, BS</last_name>
    <phone>7134862803</phone>
    <email>Jessica.N.Vincent@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Griselda Villalobos, BA</last_name>
    <phone>7134862800</phone>
    <email>Griselda.BarbaVillalobos@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Behavioral and Biomedical Sciences Building</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joy Schmitz, PhD</last_name>
      <phone>713-486-2867</phone>
      <email>Joy.M.Schmitz@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rolanda Johnson, MA</last_name>
      <phone>7134862823</phone>
      <email>Rolanda.Johnson@uth.tmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Joy M Schmitz, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Lane, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frederick G Moeller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Green, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <lastchanged_date>December 28, 2015</lastchanged_date>
  <firstreceived_date>July 11, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Joy Schmitz</investigator_full_name>
    <investigator_title>Professor - Psychiatry</investigator_title>
  </responsible_party>
  <keyword>cocaine</keyword>
  <keyword>cognition</keyword>
  <keyword>medication</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropinirole</mesh_term>
    <mesh_term>Carbidopa</mesh_term>
    <mesh_term>Levodopa</mesh_term>
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
